Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution

B SHANGHAI, April 28, 2026 /PRNewswire/ — On 28 April, Fosun Pharma (“the Company”, stock code: 600196.SH; 02196.HK) announced its results for the first quarter of…
posteditor
posteditor
Articles: 17424

Other News